… cytokine signaling (SOCS) family of phosphatases. From the perspective of immune system
function, this family of cytokines … These cytokines are key for the control of the differentiation …

… We recently demonstrated the feasibility of such an alternative approach to cancer
immunotherapy that achieves an effective concentration of cytokines in the tumor microenvironment. …

… In the last decade, cancer immunotherapy has received considerable interest in the scientific
and clinical communities, becoming a promising treatment option for various cancers, in …

… provide a timely update on the biology of IL-6 family cytokines and their clinical potential as
therapeutic targets or disease modifiers in autoimmunity, inflammation, infection and cancer. …

… to the heterogeneity of cancer theories of common reaction … with cancer, expression and
interplay of the following cytokines … of tumor growth by IFN-gamma in cancer immunotherapy. …

… cytokines TNF-α, IL-1-β and IL-6 are critical mediators in the inflammatory process of arthritis,
while the cytokine … A wide range of cytokines are currently used in passive immunotherapy …

… from inhibitory to activating cytokines in order to generate a protective anti-cancer response,
… challenge for successful immunotherapy approaches. One way that cancers evade the …

… receptor family. Overall, our results provide evidence that CCDC134 may serve as a member
of the γ c cytokine family and illustrate its … Cancer Res; 74(20); 5734–45. ©2014 AACR. …

… The advent of more effective immunotherapies and an … to harnessing cytokine networks in
the treatment of cancer, … both cytokine and anti-cytokine approaches to cancer therapy herein. …

… of cancer (1, 2). Chemokines, are a family of small, secreted, and structurally related cytokines
… They are also key mediators of cancer related inflammation being present at tumor site for …